Most a short while ago, it has been determined that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to some wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts as being a scavenger and